secwatch / observer
8-K filed April 30, 2026, 7:59 PM ET ticker HCA CIK 0000860730
debt confidence high sentiment neutral materiality 0.60

HCA Inc. issues $3B in senior notes across three tranches maturing 2031-2036

HCA Healthcare, Inc.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

HCA Healthcare, Inc. entered into Indentures with CSC Delaware Trust Company and Deutsche Bank Trust Company Americas valued at $3,000,000,000 (effective 2026-04-30).

Action
entry
Agreement
notes offering
Counterparty
CSC Delaware Trust Company and Deutsche Bank Trust Company Americas
Value
$3,000,000,000
Effective
2026-04-30
Exact text from the filing
On April 30, 2026, the Notes were issued pursuant to an indenture dated as of August 1, 2011 (the “Base Indenture”), among the Issuer, the Parent Guarantor, CSC Delaware Trust Company (formerly known as Delaware Trust Company) (as successor to Law Debenture Trust Company of New York), as trustee (the “Trustee”), and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (the “Paying Agent”), as amended and supplemented by, (i) with respect to the 2031 Notes, the Supplemental Indenture No. 54, dated as of April 30, 2026, among the Issuer, the Parent Guarantor, the Trustee and the Paying Agent (together with the Base Indenture, the “2031 Notes Indenture”); (ii) with respect to the 2033 Notes, the Supplemental Indenture No. 55, dated as of April 30, 2026, among the Issuer, the Parent Guarantor, the Trustee and the Paying Agent (together with the Base Indenture, the “2033 Notes Indenture”); and (iii) with respect to the 2036 Notes, the Supplemental Indenture No
View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

HCA Healthcare, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-26-197278
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.